Stocks make money

Stocks to make money_how to buy stocks to make money

Issuing shares to buy stocks of assets

Commerzbank’s chief economist Joerg Kraemer said in a report on Tuesday that as the outlook deteriorates, ECB officials in Frankfurt may cut deposit rates by 10 basis points atIssuing shares to buy stocks of assets the meeting next week and increase the monthly bond purchase scale by 200 Billion euros.

On August 13, Weikang Pharmaceutical (300878) and Jinchun shares (300877) disclosed the online subscription status and the announcement of the winning rate. So far, 18 new shares have disclosed the results of the online winning rate. According to the statistics of a reporter from the Securities Times, the average winning rate is as low as 0.0177%, and the average online subscription multiple is 5742 times. It can be said that one lot is hard to find, showing that online investors are very enthusiastic about the new GEM registration system.

In addition, BYD’s total installed capacity of new energy vehicle power batteries and energy storage batteries in October was approximately 507GWh, a year-on-year increase of 156%. The cumulative total installed capacity this year was approximately 591GWh. Driven by strong sales data, BYD's AH shares rose again on Thursday, with A shares trading at a daily limit, and H shares soaring 16%, both hitting record highs, and the total market value exceeded 500 billion yuan for the first time.

On February 9, the Joint Prevention and Control Mechanism of the State Council held a press conference to introduce the production and supply of important living materials in the prevention and control of the epidemic. At the press conference, Feng Luzhao, a researcher from the Centers for Disease Control and Prevention, answered relevant questions that netizens were concerned about.

This time it is initially determined that 128 drugs will be included in the scope of the proposed negotiation, including 109 western medicines and 19 Chinese patent medicines, far exceeding the 44 varieties negotiated in 2017. The therapeutic areas of these drugs mainly involve major diseases such as cancer and rare diseases, hepatitis C, hepatitis B, and chronic diseases such as hypertension and diabetes. Industry insiders believe that the scope of this negotiation has greatly expanded compared with the 44 medical insurance negotiation scopes in 2017 and the 18 medical insurance negotiation scopes in 2018, reflecting the support for the availability of innovative drugs at home and abroad. The complete list of 128 drugs has not been disclosed this time, and will be announced later.

Judging from the rIssuing shares to buy stocks of assetsanking of securities companies in terms of the number of underwriting, the three are still in the top three. As of December 17, CITIC Securities (600030), CITIC Construction Investment (601066), and CICC (601995) have maintained their top three positions, and the ranking remains unchanged from last year. The number of underwriters is 37, 33, and 30 respectively. Home.

On Tuesday, local time, the international rating agency Fitch released the latest crude oil price forecast. Surprisingly, Fitch raised its 2020 crude oil price forecast, but lowered its 2022 crude oil price forecast, leaving its 2021 oil price forecast unchanged.

□Chloroquine Phosphate: It is an antimalarial drug that has been on the market for many years, and its safety is guaranteed. In vitro experiments have shown that it has a good inhibitory effect on the new coronavirus. Preliminary clinical results show that chloroquine phosphate has a certain diagnosis and treatment effect on new coronary pneumonia.